STOCK TITAN

Bespoke Extracts expects Q3 report beyond extension

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(High)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
NT 10-Q

Rhea-AI Filing Summary

Bespoke Extracts, Inc. (BSPK) said it cannot file its September 30, 2026 Form 10-Q until its 2025 Form 10-K and March and June 2026 Forms 10-Q are completed and filed. It does not expect to file within Rule 12b-25(b)'s five-calendar-day period. Revenue was estimated at approximately $498,000, versus $467,945 a year earlier; the preliminary estimate is unaudited and subject to change. It could not estimate net loss while financial statement preparation and closing review remained incomplete.

1 point · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

1 major · 1 point

How the balance works

Positive

  • Moderate pointPreliminary quarterly revenue estimate rose to approximately $498,000 from $467,945.

Negative

  • Major pointThree earlier reports remain unfiled, delaying the September-quarter Form 10-Q.
Estimated quarterly revenue Approximately $498,000 Quarter ended September 30, 2026; preliminary, unaudited estimate subject to change
Prior-year quarterly revenue $467,945 Quarter ended September 30, 2025
Unfiled periodic reports 3 reports 2025 Form 10-K and Forms 10-Q for the quarters ended March 31 and June 30, 2026
Rule 12b-25(b) period 5 calendar days The company does not expect to file the September 2026 Form 10-Q within this period
Rule 12b-25(b) regulatory
"five-calendar-day period provided by Rule 12b-25(b)"
interim financial statements financial
"The interim financial statements to be included in the Form 10-Q"
Interim financial statements are condensed financial reports covering a short period within a fiscal year—commonly a quarter or month—showing a company’s revenue, expenses, cash flow and snapshot of assets and liabilities for that period. They matter to investors because they provide an up-to-date, mid-year scorecard of performance and trends between annual reports, helping spot improving or deteriorating prospects so decisions can be timed appropriately.
closing procedures financial
"closing procedures and final review of operating expenses"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What revenue did BSPK estimate for the September 2026 quarter?

Bespoke Extracts estimated revenue of approximately $498,000 for the quarter ended September 30, 2026, compared with $467,945 for the quarter ended September 30, 2025. It attributed the increase to sales across its product lines and said the preliminary, unaudited estimate is subject to change.

Why can't BSPK file its September 2026 Form 10-Q?

The September-quarter interim statements include a December 31, 2025 balance sheet derived from audited financial statements, and BSPK said its 2025 Form 10-K and March and June 2026 Forms 10-Q must be completed and filed first. It said preparing those reports requires additional time.

Will BSPK file its September 2026 Form 10-Q within the extension period?

No. BSPK said it does not expect to file the September 30, 2026 Form 10-Q within the five-calendar-day period under Rule 12b-25(b). It is working to complete and file all delinquent periodic reports as promptly as practicable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 12b-25

  

NOTIFICATION OF LATE FILING

 

(Check One): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR

 

For Period Ended: September 30, 2026

 

  ☐ Transition Report on Form 10-K
  ☐ Transition Report on Form 20-F
  ☐ Transition Report on Form 11-K
  ☐ Transition Report on Form 10-Q
  ☐ Transition Report on Form N-CEN

For the Transition Period Ended: ________________________

 

Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

 

If the notification relates to a portion of the filing checked above, identify the item(s) to which the notification relates:

 

PART I — REGISTRANT INFORMATION

 

Bespoke Extracts, Inc.

Full Name of Registrant

 

Former Name if Applicable

 

12001 E. 33rd Avenue, Unit O

Address of Principal Executive Office (Street and Number)

 

Aurora, CO, 80010

City, State and Zip Code

 

  

PART II — RULES 12b-25(b) AND (c)

 

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate.)

 

  (a) The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;

 

☐

(b) The subject annual report, semi-annual report, transition report on Form 10-K, Form  20-F, Form 11-K, Form N-CEN or Form  N-CSR, or portion thereof, will be filed  on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the  prescribed due date; and
  (c) The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

 

PART III— NARRATIVE

 

State below in reasonable detail why the Form 10-K, 20-F, 11-K, 10-Q, 10-D, N-CEN, N-CSR or the transition report portion thereof, could not be filed within the prescribed time period. (Attach extra sheets if needed.)

 

The Company has not yet filed its Annual Report on Form 10-K for the fiscal year ended December 31, 2025 or its Quarterly Report on Form 10-Q for the quarter ended March 31, 2026 or for the quarter ended June 30, 2026. The Company requires additional time to complete the preparation of the financial statements and related disclosures required to be included in those reports. The interim financial statements to be included in the Form 10-Q for the quarter ended September 30, 2026 include a balance sheet as of December 31, 2025 derived from the Company’s audited financial statements for that year, and the Annual Report on Form 10-K for the fiscal year ended December 31, 2025 and the Forms 10-Q for the quarters ended March 31, 2026 and June 30, 2026 must be completed and filed first. Accordingly, the Company is unable to complete and file the Form 10-Q for the quarter ended September 30, 2026 until those reports have been completed. These conditions could not be eliminated without unreasonable effort or expense. The Company is working to complete and file all delinquent periodic reports as promptly as practicable and does not expect to file the Form 10-Q for the quarter ended September 30, 2026 within the five-calendar-day period provided by Rule 12b-25(b).

 

PART IV — OTHER INFORMATION

 

(1) Name and telephone number of person to contact in regard to this notification

 

Michael Feinsod   720   949-1143
(Name)   (Area Code)   (Telephone Number)

 

(2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If the answer is no, identify report(s). ☐ Yes ☒ No

 

Annual Report on Form 10-K for the fiscal year ended December 31, 2025
Quarterly Report on Form 10-Q for the quarter ended March 31, 2026

Quarterly Report on Form 10-Q for the quarter ended June 30, 2026

 

(3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? ☒ Yes ☐ No

 

If so: attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

 

The Company estimates that revenue for the quarter ended September 30, 2026, increased to approximately $498,000 from $467,945 for the quarter ended September 30, 2025. The increase is due to increased sales across its product lines. The foregoing estimate is preliminary, unaudited and subject to change upon completion of the Company’s closing procedures and the preparation and review of its financial statements, and is not a guarantee of actual results. The Company is unable at this time to provide a reasonable estimate of its net loss for the quarter ended September 30, 2026 because the financial statements for the fiscal year ended December 31, 2025 and the quarters ended March 31, 2026 and June 30, 2026 have not been completed, and its closing procedures and final review of operating expenses and related accruals for the quarter ended September 30, 2026 remain in process.

 

2

  

Bespoke Extracts, Inc.

 

(Name of Registrant as Specified in Charter)

 

Has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: November 17, 2026 By:  /s/ Michael Feinsod
  Name:  Michael Feinsod
  Title: Chief Executive Officer and
Chief Financial Officer

 

3

 

Keep reading